MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,265
Unique beneficiaries
—
Total services
3,073
Distinct HCPCS
17
Medicare payment
$183K
Peer benchmark
Total Medicare services vs. 2,306 Internal Medicine providers in MD — top quintile (cohort median 884).
PRESCRIBING · PART D · 2024
Total Rx claims
2,844
Beneficiaries
—
Total drug cost
$129K
Distinct drugs
64
Brand share
23.3%
Top prescribed drugs
Triamterene/Hydrochlorothiazid305 claims
Losartan Potassium187 claims
Atorvastatin Calcium150 claims
Amlodipine Besylate135 claims
Tamsulosin Hcl112 claims
QUALITY · MIPS · 2024
Final MIPS score
23.9
Quality
0.0
Cost
79.7
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.13%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Peter Stamas's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Cd Laboratories, Inc. Clinical Laboratory · Baltimore, MD | 236 | 894 |
| GREATER BALTIMORE MEDICAL CENTER, INC. | 62 | 287 |
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 24 | 53 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 15 | 38 |
| UNIVERSITY OF MARYLAND ST. JOSEPH MEDICAL CENTER, LLC | 15 | 50 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE